J07AE02 - Cholera, Live Attenuated |
Probably not porphyrinogenic |
PNP |
Mono.Rationale
Based on the pharmacokinetics of the Live attenuated cholera vaccine, no porphyrinogenic effects are expected.
Mono.ChemicalDescription
Live attenuated virus vaccine.
Mono.TherapeuticCharacteristics
Indicated for active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years and older. The vaccine is administered orally.
Mono.MetabolismAndPharmacokinetics
Vaccines are not metabolized by the cytochrome P450 system.
Mono.SimilarDrugs
Mono.References
| # | Citation details | PubMed ID |
|---|---|---|
| Government bodies | ||
| 1. | European Medicines Agency (EMA). SmPC Vaxchora.
|
|
| 2. | Norwegian institute of public health. Vaccines and vaccination.
|
|
Mono.Tradenames
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora vaccine 
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora 
Dukoral · Orochol Berna 
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora 
Vaxchora 
Vaccines 
Vaxchora